This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Takayo Murase: Innovator in Pharmaceutical Chemistry
Introduction
Takayo Murase is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on dipeptidyl peptidase IV inhibitors. His research focuses on developing compounds that exhibit high activity, stability, and safety as pharmaceutical agents.
Latest Patents
Murase holds a patent for a compound inhibiting dipeptidyl peptidase IV. This compound is characterized by its excellent action as a pharmaceutical agent. The patent describes a compound represented by a specific general formula, which includes various substituents and functional groups that enhance its efficacy.
Career Highlights
Murase is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been instrumental in advancing research in pharmaceutical compounds. His work has led to the development of innovative solutions that address critical health issues.
Collaborations
Murase has collaborated with notable colleagues, including Takuji Kakigami and Mitsuru Oka. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical agents.
Conclusion
Takayo Murase's contributions to pharmaceutical chemistry, particularly in the development of dipeptidyl peptidase IV inhibitors, highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile